Elantas Beck India Ltd vs Epigral Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Elantas Beck India Ltd is ₹ 7582 as of 18 Mar 15:30 . The P/E Ratio of Elantas Beck India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 years The Market Cap of Elantas Beck India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 years The revenue of Elantas Beck India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The ebitda of Elantas Beck India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The net profit of Elantas Beck India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The dividend payout of Elantas Beck India Ltd changed from 5.93 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Epigral Ltd changed from 5.88 % to 7.26 % over 3 quarters. This represents a CAGR of 32.46% .

About Elantas Beck India Ltd

Elantas Beck India Limited, formerly known as Beck India Limited, incorporated on March 15, 1956 is a subsidiary of Elantas GmbH Company based in Germany.
Elantas GmbH is part of Altana Group whose Ultimate Holding Company is SKion GmbH. The Company changed the name from Beck India Limited to Elantas Beck India Limited on June 19, 2007.
At present, Company manufactures specialty chemicals for electrical insulation and construction industries.
It has manufacturing plants at Pimpri and Ankleshwar in India. The Company was promoted by Mahindra & Mahindra in collaboration with Dr Beck & Company, Germany.
It went public in 1961.

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

FAQs for the comparison of Elantas Beck India Ltd and Epigral Ltd

Which company has a larger market capitalization, Elantas Beck India Ltd or Epigral Ltd?

Market cap of Elantas Beck India Ltd is 6,011 Cr while Market cap of Epigral Ltd is 3,694 Cr

What are the key factors driving the stock performance of Elantas Beck India Ltd and Epigral Ltd?

The stock performance of Elantas Beck India Ltd and Epigral Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Elantas Beck India Ltd and Epigral Ltd?

As of March 18, 2026, the Elantas Beck India Ltd stock price is INR ₹7582.3. On the other hand, Epigral Ltd stock price is INR ₹856.45.

How do dividend payouts of Elantas Beck India Ltd and Epigral Ltd compare?

To compare the dividend payouts of Elantas Beck India Ltd and Epigral Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.